Skip to content

Welcome to Discover Pharma! Today is : November 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Brain Cancer

  • Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    SurVaxM improves survival in Phase 2b glioblastoma trial

    MimiVax’s SurVaxM cancer vaccine improved overall survival in a Phase [...]

    October 12, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Vaximm reports encouraging VXM01 data in recurrent glioblastoma studies

    Vaximm AG has completed analysis of two clinical studies evaluating [...]

    August 3, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    PhoreMost advances brain cancer candidate PMC-001 towards Phase 1

    PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]

    June 11, 2026
  • Biotech & Pharma Business,Central Nervous System,Drug Discovery & Development

    Deep Science Ventures and Medicines Discovery Catapult target blood-brain barrier challenge

    Deep Science Ventures and Medicines Discovery Catapult have launched a [...]

    June 6, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    CNS Pharmaceuticals announces primary analysis of Berubicin in second line treatment of glioblastoma multiforme

    CNS Pharmaceuticals has reported the primary analysis of its clinical [...]

    May 5, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    FDA and Telix agree resubmission plan for Pixclara glioma imaging agent

    Telix Pharmaceuticals has reached agreement with the US Food and [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    New glioblastoma treatment project secures funding from The Brain Tumour Charity

    Medicines Discovery Catapult (MDC) and King’s College London (KCL) have [...]

    May 5, 2026
  • Drug Delivery & Formulation

    Carthera hits major recruitment milestone in glioblastoma trial using BBB-opening ultrasound device

    Carthera has enrolled the first 100 participants in its Sonobird [...]

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • AmplexDiagnostics launches rapid Candida auris resistance test
    Categories: Clinical & Regulatory, Medical devices, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • SeaBeLife secures €2.9m to advance acute liver injury drug
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Gesynta Pharma completes recruitment in endometriosis trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top